Hemodynamic and myocardial metabolic effects of the beta-agonist prenalterol in ischemic left ventricular dysfunction.

Hemodynamic and myocardial metabolic parameters in ischemic left ventricular (LV) dysfunction were evaluated in response to the beta-agonist prenalterol. Twenty micrograms/kg intravenous prenalterol increased resting heart rate and cardiac output and decreased LV filling pressure, systemic vascular resistance, and pulmonary artery pressure. Resting coronary blood flow and myocardial oxygen consumption increased but net myocardial lactate and oxygen extraction did not change significantly. During pacing induced tachycardia (121 +/- 4 beats/min), prenalterol improved cardiac index and stroke work index; whereas, LV filling pressure, systemic vascular resistance, and pulmonary artery pressure decreased. Coronary blood flow and myocardial oxygen extraction did not change significantly. Net myocardial lactate extraction during pacing decreased insignificantly; one patient developed overt lactate production. Thus, prenalterol improves cardiovascular function at rest and during pacing-induced tachycardia in ischemic LV failure, but at the cost of higher resting myocardial oxygen consumption. The majority of subjects had no adverse metabolic response.
AuthorsP C Kirlin, J A Walton Jr, J F Brymer, G Beauman, B Pitt
JournalJournal of cardiovascular pharmacology (J Cardiovasc Pharmacol) 1984 Sep-Oct Vol. 6 Issue 5 Pg. 852-8 ISSN: 0160-2446 [Print] UNITED STATES
PMID6209491 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Adrenergic beta-Agonists
  • Cardiotonic Agents
  • Prenalterol
  • Practolol
  • Adrenergic beta-Agonists (pharmacology)
  • Adult
  • Cardiotonic Agents (pharmacology)
  • Coronary Circulation (drug effects)
  • Coronary Disease (physiopathology)
  • Female
  • Hemodynamics (drug effects)
  • Humans
  • Male
  • Middle Aged
  • Myocardium (metabolism)
  • Oxygen Consumption (drug effects)
  • Practolol (analogs & derivatives, pharmacology)
  • Prenalterol

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: